EP Patent

EP3231420A1 — Abuse-deterrent pharmaceutical compositions

Assigned to GL Pharma GmbH · Expires 2017-10-18 · 9y expired

What this patent protects

Disclosed are pharmaceutical compositions comprising a drug with a laccase-reactive functional group and a laccase (EC 1.10.3.2) and methods for manufacturing such compositions.

USPTO Abstract

Disclosed are pharmaceutical compositions comprising a drug with a laccase-reactive functional group and a laccase (EC 1.10.3.2) and methods for manufacturing such compositions.

Drugs covered by this patent

chembl-chembl2103744 (MORPHINE SULFATE)

Patent Metadata

Patent number: EP3231420A1
Jurisdiction: EP
Classification: —
Expires: 2017-10-18
Drug substance claim: No
Drug product claim: No
Assignee: GL Pharma GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.